
90.82 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 18.47 Today|||52-Week Range 95.00 | +139.06% Year-to-Date |
Entera Bio Ltd. (ENTX) Reports Q4 Loss, Lags Revenue Estimates 5:15pm / Zacks.com - Paid Partner Content | Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates Mar 21 / Zacks.com - Paid Partner Content |
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates Mar 30 / Zacks.com - Paid Partner Content | 3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing Mar 19 / MotleyFool.com - Paid Partner Content |
Previous close | 90.02 |
Today’s open | 89.22 |
Day’s range | 88.05 - 93.07 |
Volume | 37,611 |
Average volume (3 months) | 1,165,650 |
Market cap | $3.1B |
Earnings growth (last year) | -4.32% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -80.71% |
P/E ratio | NM |
Price/Sales | 626.04 |
Price/Book | -- |
---- | ||
ISEEIVERIC bio Inc | +0.55 | +2.29% |
CYTKCytokinetics Inc | +0.98 | +2.86% |
FOLDAmicus Therapeutics ... | +0.19 | +1.74% |
Last reporting date | March 31, 2023 |
EPS forecast (this quarter) | -$2.35 |
Annual revenue (last year) | $2.2M |
Annual profit (last year) | -$311.9M |
Net profit margin | -14,074.95% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |